Evidence map›Paper›PMID 28642706›Full record

ArticleFrontiers in pharmacology2017

Toll-Like Receptor 4 Modulates Small Intestine Neuromuscular Function through Nitrergic and Purinergic Pathways.

Valentina Caputi, Ilaria Marsilio, Silvia Cerantola, Mona Roozfarakh, Isabella Lante, Francesca Galuppini, Massimo Rugge, Eleonora Napoli, Cecilia Giulivi, Genny Orso and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. The enteric nervous system.Physiological reviews · 2023
    Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Effect of combined farnesoid X receptor agonist and angiotensin II type 1 receptor blocker on ongoing hepatic fibrosis.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2022
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

Valentina CaputiDepartment of Pharmaceutical and Pharmacological Sciences, School of Medicine, University of PadovaPadova, Italy.
Ilaria MarsilioDepartment of Pharmaceutical and Pharmacological Sciences, School of Medicine, University of PadovaPadova, Italy.
Silvia CerantolaDepartment of Pharmaceutical and Pharmacological Sciences, School of Medicine, University of PadovaPadova, Italy.
Mona RoozfarakhMedway School of Pharmacy, Universities of Kent and Greenwich at MedwayKent, United Kingdom.
Isabella LanteSan Camillo HospitalTreviso, Italy.
Francesca GaluppiniDepartment of Medicine, University of PadovaPadova, Italy.
Massimo RuggeDepartment of Medicine, University of PadovaPadova, Italy.
Eleonora NapoliDepartment of Molecular Biosciences, School of Veterinary Medicine, University of California, Davis, DavisCA, United States.
Cecilia GiuliviDepartment of Molecular Biosciences, School of Veterinary Medicine, University of California, Davis, DavisCA, United States.
Genny OrsoIRCCS "E. Medea" Bosisio PariniLecco, Italy.
Maria Cecilia GironDepartment of Pharmaceutical and Pharmacological Sciences, School of Medicine, University of PadovaPadova, Italy.
University of Padua · ITOspedale generale di zona San Camillo Treviso · ITUniversity of California, Davis · USIRCCS Eugenio Medea · ITMedway School of Pharmacy · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

enteric nervous systemgut microbiotainnate immunityintestinal motilityintestinal transitknockout micesmall boweltoll-like receptor 4

Identifiers

PMID28642706
PMCPMC5463746
OpenAlexW2626752632

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.